Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma-Reference-Cited by-同舟云学术

Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma

Published:2015-03-11 Issue:1 Volume:49 Page:293-299
ISSN:1010-7940
Container-title:European Journal of Cardio-Thoracic Surgery
language:en
Short-container-title:Eur J Cardiothorac Surg

Author:

Tsubokawa Norifumi,Mimae Takahiro,Sasada Shinsuke,Yoshiya Tomoharu,Mimura Takeshi,Murakami Shuji,Ito Hiroyuki,Miyata Yoshihiro,Nakayama Haruhiko,Okada Morihito

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

http://academic.oup.com/ejcts/article-pdf/49/1/293/8067236/ezv058.pdf

Reference25 articles.

1. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

2. Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis

3. Evolving Concepts in the Pathology and Computed Tomography Imaging of Lung Adenocarcinoma and Bronchioloalveolar Carcinoma

4. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

5. Micropapillary Component in Lung Adenocarcinoma

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinicopathological features and possible physiological mechanisms of only the EGFR-T790M primary mutation in patients with lung adenocarcinoma;Pathology - Research and Practice;2024-07

2. Quantifying intratumoral heterogeneity within sub-regions to predict high-grade patterns in clinical stage I solid lung adenocarcinoma;2024-02-12

3. Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components;Cancer Medicine;2024-02

4. The clinicopathological features and possible physiological mechanisms of only EGFR-T790M primary mutation in lung adenocarcinoma patients;2024-01-30

5. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components;World Journal of Surgical Oncology;2024-01-25